Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 2,674 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Stanford University Clear all

Conditions: Esrd
Interventions: Ergothioneine, Placebo; Dietary Supplement · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Depression
Interventions: transcranial magnetic stimulation; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pregnancy Complications, Mental Health Issue, Depression, Anxiety, Pregnancy, High Risk, Biological Clock Disturbance
Interventions: Step count goal, Actigraph watch; Behavioral · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Leukemia, Lymphocytic, Chronic
Interventions: high dose chemotherapy then autologous hematopoietic cell transplant, ablative allogeneic hematopoietic cell transplant; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autistic Disorder
Interventions: Pacific Autism Center for Education (PACE ) developmentally based parent delivered intervention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Months to 6 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Stanford, California

Conditions: Lung Cancer
Interventions: Real time position management system, LS PET/CT, 18-FDG; Device · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Sleep, Sleep Apnea
Interventions: Dreem; Diagnostic Test
Lead sponsor: Dreem; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Myopia
Interventions: LASIK; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Stanford, California

Conditions: Lymphoma, Non-Hodgkin's Lymphoma
Interventions: Rituximab; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Head and Neck Cancer
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obesity, Childhood
Interventions: Wise interventions -- values self-affirmation and growth mindset -- plus usual care behavioral treatment, Education plus usual care behavioral treatment; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 16 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Prostate Cancer
Interventions: Photoacoustic Imaging System; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Moya Moya Disease
Interventions: Standard of Care; Other
Lead sponsor: Stanford University; Other
Eligibility: 3 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Physical Inactivity
Interventions: PA Education plus human and planetary health information, PA Education plus Our Voice citizen science; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 66 Years to 105 Years · Female only
Enrollment: 232 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Alzheimer's Disease
Interventions: Enhancing Physical Activity Intervention, CSBI; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 40 Years and older
Enrollment: 211 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 2
States / cities: Stanford, California • Chicago, Illinois

Conditions: Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
Interventions: Purified regulatory T-cells (Treg) plus CD34+ HSPC, Fludarabine, Melphalan, CliniMACS CD34 Reagent System, Tacrolimus, Cyclophosphamide, Plerixafor, Filgrastim granulocyte colony-stimulating factor (G-CSF) or equivalent, Thiotepa, Mycophenolate Mofetil (MMF), Ruxolitinib, Sirolimus; Drug · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Social Phobia
Interventions: Individual Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 21 Years to 55 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Ulcer, Wounds and Injuries
Interventions: SNaP Advanced Wound Care System, SNaP; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Interpersonal Trauma, Depression, PTSD, Anxiety, Suicidal Ideations, Sexual Assault
Interventions: BEAR-SI; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pulmonary Arterial Hypertension, Systemic Sclerosis, Scleroderma Spectrum of Diseases, Connective Tissue Disease, Pulmonary Hypertension
Interventions: tadalafil and ambrisentan upfront combination therapy; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Math Learning Disability, Learning Disabilities, Learning Disabilities, Child, Dyscalculia, Child Development
Interventions: Speeded practice training, Arithmetic strategy training; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Eating Disorder
Interventions: Training, Training and Technical Assistance, Training, Tech. Assistance, Quality Assurance/Improvement; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 17 Years and older
Enrollment: 2,261 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 4
States / cities: Stanford, California • Eugene, Oregon • Austin, Texas + 1 more

Conditions: Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia
Interventions: Tagraxofusp, Cladribine (CLAD), Cytarabine; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer
Interventions: Talazoparib Tosylate; Drug
Lead sponsor: Melinda Telli; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Repletion of Ergothioneine in Patients With Kidney Failure

Neural Circuit Biomarkers of Transcranial Magnetic Stimulation Study

Psychobiological Interventions in Pregnancy

Transplantation for Patients With Chronic Lymphocytic Leukemia

An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism

The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging

Comparison of Dreem to Clinical PSG for Sleep Monitoring in Apnea Patients

IntraLase vs Hansatome Flaps in LASIK

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers

Wise Social Psychological Interventions to Improve Outcomes of Behavioral Weight Control in Children With Obesity

Transrectal Photoacoustic Imaging of the Prostate

Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease

Testing Multi-Level Remote Physical Activity Interventions in a National Sample of Older Women: The WHISH EnCore Trial

Telephone Resources and Assistance for Caregivers (TRAC)

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia

Feasibility Study of a Novel Device for Chronic Wounds

The BEAR Program for Women With Trauma Who Have Suicidal Thoughts

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Intervention on Mathematical Problem-Solving Skills

Implementation Support for Prevention Program Delivery by College Peer Educators

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors